---
category: news
title: "Oncohost platform predicts response to lung cancer therapy"
excerpt: "Prophet, Oncohost Ltd.â€™s artificial intelligence-driven proteomics profiling platform, predicted response to immune checkpoint inhibitor (ICI) therapy in non-small-cell lung carcinoma (NSCLC) patients in a study presented at the European Society for Medical Oncology Virtual Congress 2021."
publishedDateTime: 2021-09-20T00:00:00Z
originalUrl: "https://www.bioworld.com/articles/511600-oncohost-platform-predicts-response-to-lung-cancer-therapy"
webUrl: "https://www.bioworld.com/articles/511600-oncohost-platform-predicts-response-to-lung-cancer-therapy"
type: article
quality: 39
heat: 39
published: false

provider:
  name: BioWorld
  domain: bioworld.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.bioworld.com/ext/resources/BMT-source/2020/11-4-Oncohost.png?height=635&t=1604528773&width=1200"
    width: 847
    height: 635
    isCached: true

secured: "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;X92ZQXK1+P6ZF4pLiotP6w=="
---

